A carregar...
Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19
Favipiravir is an antiviral drug that is expected to have a therapeutic effect on SARS-CoV2 infection. Teratogenicity and hyperuricemia are known as the main side effects of favipiravir, but little is known about other side effects. This report describes a case of cholestatic liver injury induced by...
Na minha lista:
| Publicado no: | J Infect Chemother |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7833994/ https://ncbi.nlm.nih.gov/pubmed/33402301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiac.2020.12.021 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|